Blood-pool selective carrier for lipophilic imaging agents
    3.
    发明授权
    Blood-pool selective carrier for lipophilic imaging agents 失效
    用于亲脂显像剂的血液池选择性载体

    公开(公告)号:US06645463B1

    公开(公告)日:2003-11-11

    申请号:US09058715

    申请日:1998-04-10

    IPC分类号: A61K5100

    摘要: A surface-modified lipoprotein-like oil-in-water emulsion useful as a blood-pool selective delivery vehicle for lipophilic imaging agents or lipophilic derivatives of water-soluble imaging agents. The blood-pool selective delivery vehicle remains in the blood for several hours, shows very little early hepatic sequestration, and is cleared from the blood within 24 hours. The mean diameter of the oil phase is less than 150 nm which minimizes sequestration by the reticuloendothelial system. The surface of the oil phase is modified with a polyethyl glycol-modified phospholipid to prevent normal interactions with the receptor sites of the hepatocytes. In radiographic imaging, radioactive or stable, synthetic or semi-synthetic polyhalogenated triglycerides, such as 2-oleoylglycerol-1,3-bis[7-(3-amino-2,4,6-triiodophenyl)heptanoate], or lipid soluble derivatives of traditional water-soluble contrast agents, such as aliphatic esters of iopanoic, diatrizoic, and acetrizoic acid, may be incorporated into the lipophilic core of a lipoprotein-like emulsion particle.

    摘要翻译: 用作脂溶性成像剂或水溶性成像剂的亲脂性衍生物的血液池选择性递送载体的表面改性脂蛋白样水包油乳液。 血液池选择性输送载体在血液中保持数小时,显示出非常少的早期肝脏螯合,并在24小时内从血液中清除。 油相的平均直径小于150nm,其最小化网状内皮系统的螯合。 用聚乙二醇修饰的磷脂修饰油相的表面以防止与肝细胞的受体位点的正常相互作用。 放射摄影成像中,放射性或稳定的合成或半合成多卤甘油三酸酯如2-油酰甘油-1,3-双[7-(3-氨基-2,4,6-三碘苯基)庚酸酯]或脂溶性衍生物 的传统的水溶性造影剂,如碘,脂肪族和代谢酸的脂肪族酯可以并入脂蛋白样乳液颗粒的亲脂性核心中。

    Polyiodinated triglyceride analogs as radiologic agents
    4.
    发明授权
    Polyiodinated triglyceride analogs as radiologic agents 失效
    多碘化甘油三酯类似物作为放射剂

    公开(公告)号:US4873075A

    公开(公告)日:1989-10-10

    申请号:US774498

    申请日:1985-09-10

    摘要: Novel iodinated arylaliphatic triglyceride analogs, as radiologic agents are liver and hepatocyte site-specific. The triglyceride backbone structure is preferably 1,3-disubstituted or 1,2,3-trisubstituted with, in some embodiments, a 3-substituted-2,4,6-triiodophenyl aliphatic chain wherein the chain has a structure similar to naturally occurring fatty acids. In another embodiment, a monoiodophenyl aliphatic chain is utilized. Any position remaining on the triglyceride backbone is substituted with a saturated or unsaturated aliphatic hydrocarbon chain of the type found in naturally occurring fatty acids. The triglyceride analogs can be radioiodinated. In a preferred embodiment, a lipid emulsion is provided as the carrier vehicle.

    摘要翻译: 新型碘化芳基脂肪酸甘油三酯类似物,作为放射剂是肝和肝细胞位点特异性。 甘油三酯主链结构优选在一些实施方案中被3-取代-2,4,6-三碘苯基脂族链进行1,3-二取代或1,2,3-三取代,其中链具有类似于天然存在的脂肪 酸。 在另一个实施方案中,使用单碘苯基脂族链。 在甘油三酯主链上残留的任何位置被天然存在的脂肪酸中所发现类型的饱和或不饱和脂族烃链所取代。 甘油三酯类似物可以放射性碘化。 在优选的实施方案中,提供脂质乳剂作为载体载体。

    Blood-pool carrier for lipophilic imaging agents
    5.
    发明授权
    Blood-pool carrier for lipophilic imaging agents 失效
    用于亲脂显像剂的血液池载体

    公开(公告)号:US07582279B2

    公开(公告)日:2009-09-01

    申请号:US10692311

    申请日:2003-10-23

    IPC分类号: A61K51/00 A61M36/14

    摘要: A surface-modified lipoprotein-like oil-in-water emulsion useful as a blood-pool selective delivery vehicle for lipophilic imaging agents or lipophilic derivatives of water-soluble imaging agents. The blood-pool selective delivery vehicle remains in the blood for several hours, shows very little early hepatic sequestration, and is cleared from the blood within 24 hours. The mean diameter of the oil phase is less than 150 nm which minimizes sequestration by the reticuloendothelial system. The surface of the oil phase is modified with a polyethyl glycol-modified phospholipid to prevent normal interactions with the receptor sites of the hepatocytes. In radiographic imaging, radioactive or stable, synthetic or semi-synthetic polyhalogenated triglycerides, such as 2-oleoylglycerol-1,3-bis[7-(3-amino-2,4,6-triiodophenyl)heptanoate], or lipid soluble derivatives of traditional water-soluble contrast agents, such as aliphatic esters of iopanoic, diatrizoic, and acetrizoic acid, may be incorporated into the lipophilic core of a lipoprotein-like emulsion particle.

    摘要翻译: 用作脂溶性成像剂或水溶性成像剂的亲脂性衍生物的血液池选择性递送载体的表面改性脂蛋白样水包油乳液。 血液池选择性输送载体在血液中保持数小时,显示出非常少的早期肝脏螯合,并在24小时内从血液中清除。 油相的平均直径小于150nm,其最小化网状内皮系统的螯合。 用聚乙二醇修饰的磷脂修饰油相的表面以防止与肝细胞的受体位点的正常相互作用。 放射摄影成像中,放射性或稳定的合成或半合成多卤甘油三酸酯如2-油酰甘油-1,3-双[7-(3-氨基-2,4,6-三碘苯基)庚酸酯]或脂溶性衍生物 的传统的水溶性造影剂,如碘,脂肪族和代谢酸的脂肪族酯可以并入脂蛋白样乳液颗粒的亲脂性核心中。

    Hepatocyte-selective oil-in-water emulsion
    6.
    发明授权
    Hepatocyte-selective oil-in-water emulsion 失效
    肝细胞选择性水包油乳剂

    公开(公告)号:US6103216A

    公开(公告)日:2000-08-15

    申请号:US737429

    申请日:1996-11-15

    摘要: A heat and shelf-stable oil-in-water emulsion useful as a tissue or cell-selective delivery vehicle. Radioactive or stable, synthetic or semi-synthetic polyhalogenated triglycerides, such as 2-oleoylglycerol-1,3-bis[7-(3-amino-2,4,6-triiodophenyl)heptanoate] or 2-oleoylglycerol-1,3-bis[.omega.-(3,5-bis-trifluoromethyl)-heptanoate] or phenyl acetate, can be incorporated into the lipophilic core of a lipoprotein-like emulsion particle. The lipophilic core is surrounded by a phospholipid membrane comprising cholesterol and apolipoproteins. For hepatocyte-selective delivery, the emulsion is chylomicron remnant-like by being in a size range of 50 to 200 nm as measured by number weighting analysis with a narrow size distribution (

    摘要翻译: PCT No.PCT / US95 / 05974 371日期1996年11月15日 102(e)日期1996年11月15日PCT提交1995年5月16日PCT公布。 公开号WO95 / 31181 日期1995年11月23日用作组织或细胞选择性递送载体的热稳定的水包油乳液。 放射性或稳定的合成或半合成多卤甘油三酸酯,如2-油酰甘油-1,3-双[7-(3-氨基-2,4,6-三碘苯基)庚酸酯]或2-油酰甘油-1,3-二 双(ω-(3,5-双 - 三氟甲基) - 庚酸酯]或乙酸苯酯可加入脂蛋白样乳液颗粒的亲脂性核心中。 亲脂性核被包含胆固醇和载脂蛋白的磷脂膜包围。 对于肝细胞选择性递送,通过具有窄尺寸分布的数量加权分析(<3%大于300nm)测量并具有自然模拟的组成,通过在50至200nm的尺寸范围内,乳液是乳糜微粒残留的 发生乳糜微粒残留物。 在乳液配方中使用胆固醇促进载脂蛋白,特别是由肝细胞识别并且是结合和摄取所必需的Apo E的缔合。 稳定性和尺寸限制可以通过超高能量混合设备(例如MicroFluidizer(Microfluidics Corp.,Newton,Mass。))来实现,以形成乳液。 在优选的实施方案中,乳液的重量摩尔渗透压浓度由甘油而不是生理盐水控制。

    Hepatocyte-selective oil-in-water emulsion
    7.
    发明授权
    Hepatocyte-selective oil-in-water emulsion 失效
    肝细胞选择性水包油乳剂

    公开(公告)号:US5851510A

    公开(公告)日:1998-12-22

    申请号:US243596

    申请日:1994-05-16

    摘要: A heat and shelf-stable oil-in-water emulsion useful as a tissue or cell-selective delivery vehicle. Radioactive or stable, synthetic or semi-synthetic polyhalogenated triglycerides, such as 2-oleoylglycerol-1,3-bis�7-(3-amino-2,4,6-triiodophenyl)heptanoate! or 2-oleoylglycerol-1,3-bis�.omega.-(3,5-bis-trifluoromethyl)heptanoate! or phenyl acetate, can be incorporated into the lipophilic core of a lipoprotein-like emulsion particle. The lipophilic core is surrounded by a phospholipid membrane comprising cholesterol and apolipoproteins. For hepatocyte-selective delivery, the emulsion is chylomicron remnant-like by being in a size range of 50 to 200 nm as measured by number weighting analysis with a narrow size distribution (

    摘要翻译: 可用作组织或细胞选择性递送载体的热和储存稳定的水包油乳液。 放射性或稳定的合成或半合成多卤甘油三酸酯,如2-油酰甘油-1,3-双[7-(3-氨基-2,4,6-三碘苯基)庚酸酯]或2-油酰甘油-1,3-二 双(ω-(3,5-双 - 三氟甲基)庚酸酯]或乙酸苯酯可以掺入脂蛋白样乳液颗粒的亲脂性核心中。 亲脂性核被包含胆固醇和载脂蛋白的磷脂膜包围。 对于肝细胞选择性递送,通过具有窄尺寸分布的数量加权分析(<3%大于300nm)测量并具有自然模拟的组成,通过在50至200nm的尺寸范围内,乳液是乳糜微粒残留的 发生乳糜微粒残留物。 在乳液配方中使用胆固醇促进载脂蛋白,特别是由肝细胞识别并且是结合和摄取所必需的Apo E的缔合。 通过使用诸如MicroFluidizer(Microfluidics Corp.,Newton,Mass。)的超高能量混合设备可以实现稳定性和尺寸限制以形成乳液。 在优选的实施方案中,乳液的重量摩尔渗透压浓度由甘油而不是生理盐水控制。

    Hepatocyte-selective oil-in-water emulsion
    8.
    发明授权
    Hepatocyte-selective oil-in-water emulsion 失效
    肝细胞选择性水包油乳剂

    公开(公告)号:US6126946A

    公开(公告)日:2000-10-03

    申请号:US899411

    申请日:1997-07-23

    摘要: A heat and shelf-stable oil-in-water emulsion useful as a tissue or cell-selective delivery vehicle. Radioactive or stable, synthetic or semi-synthetic polyhalogenated triglycerides, such as 2-oleoylglycerol-1,3-bis[7-(3-amino-2,4,6-triiodophenyl)heptanoate] or 2-oleoylglycerol-1,3-bis[.omega.-(3,5-bis-trifluoromethyl)hepatanoate] or phenyl acetate, can be incorporated into the lipophilic core of a lipoprotein-like emulsion particle. The lipophilic core is surrounded by a phospholipid membrane comprising cholesterol and apolipoproteins. For hepatocyte-selective delivery, the emulsion is chylomicron remnant-like by being in a size range of 50 to 200 nm as measured by number weighting analysis with a narrow size distribution (

    摘要翻译: 可用作组织或细胞选择性递送载体的热和储存稳定的水包油乳液。 放射性或稳定的合成或半合成多卤甘油三酸酯,如2-油酰甘油-1,3-双[7-(3-氨基-2,4,6-三碘苯基)庚酸酯]或2-油酰甘油-1,3-二 双(ω-(3,5-双 - 三氟甲基)肝酸酯]或乙酸苯酯可以加入脂蛋白样乳液颗粒的亲脂性核心中。 亲脂性核被包含胆固醇和载脂蛋白的磷脂膜包围。 对于肝细胞选择性递送,通过具有窄尺寸分布的数量加权分析(<3%大于300nm)测量并具有自然模拟的组成,通过在50至200nm的尺寸范围内,乳液是乳糜微粒残留的 发生乳糜微粒残留物。 在乳液配方中使用胆固醇促进载脂蛋白,特别是由肝细胞识别并且是结合和摄取所必需的Apo E的缔合。 通过使用诸如MicroFluidizer(Microfluidics Corp.,Newton,Mass。)的超高能量混合设备可以实现稳定性和尺寸限制以形成乳液。 在优选的实施方案中,乳液的重量摩尔渗透压浓度由甘油而不是生理盐水控制。

    Method of making hepatocyte-selective oil-in-water emulsion
    9.
    发明授权
    Method of making hepatocyte-selective oil-in-water emulsion 失效
    制备肝细胞选择性水包油乳液的方法

    公开(公告)号:US5985941A

    公开(公告)日:1999-11-16

    申请号:US497283

    申请日:1995-06-30

    摘要: A heat and shelf-stable oil-in-water emulsion useful as a tissue or cell-selective delivery vehicle. Radioactive or stable, synthetic or semi-synthetic polyhalogenated triglycerides, such as 2-oleoylglycerol-1,3-bis[7-(3-amino-2,4,6-triiodophenyl)heptanoate] or 2-oleoylglycerol-1,3-bis[.omega.-(3,5-bis-trifluoromethyl)hepatanoate] or phenyl acetate, can be incorporated into the lipophilic core of a lipoprotein-like emulsion particle. The lipophilic core is surrounded by a phospholipid membrane comprising cholesterol and apolipoproteins. For hepatocyte-selective delivery, the emulsion is chylomicron remnant-like by being in a size range of 50 to 200 nm as measured by number weighting analysis with a narrow size distribution (

    摘要翻译: 可用作组织或细胞选择性递送载体的热和储存稳定的水包油乳液。 放射性或稳定的合成或半合成多卤甘油三酸酯,如2-油酰甘油-1,3-双[7-(3-氨基-2,4,6-三碘苯基)庚酸酯]或2-油酰甘油-1,3-二 双(ω-(3,5-双 - 三氟甲基)肝酸酯]或乙酸苯酯可以加入脂蛋白样乳液颗粒的亲脂性核心中。 亲脂性核被包含胆固醇和载脂蛋白的磷脂膜包围。 对于肝细胞选择性递送,通过具有窄尺寸分布的数量加权分析(<3%大于300nm)测量并具有自然模拟的组成,通过在50至200nm的尺寸范围内,乳液是乳糜微粒残留的 发生乳糜微粒残留物。 在乳液配方中使用胆固醇促进载脂蛋白,特别是由肝细胞识别并且是结合和摄取所必需的Apo E的缔合。 通过使用诸如MicroFluidizer(Microfluidics Corp.,Newton,Mass。)的超高能量混合设备可以实现稳定性和尺寸限制以形成乳液。 在优选的实施方案中,乳液的重量摩尔渗透压浓度由甘油而不是生理盐水控制。

    Polyiodinated triglyceride analogs as radiologic agents
    10.
    发明授权
    Polyiodinated triglyceride analogs as radiologic agents 失效
    多碘化甘油三酯类似物作为放射剂

    公开(公告)号:US5093042A

    公开(公告)日:1992-03-03

    申请号:US511450

    申请日:1990-04-20

    摘要: Novel iodinated arylaliphatic triglyceride analogs as radiologic agents are liver and hepatocyte site-specific. The triglyceride backbone structure is preferably 1,3-disubstituted or 1,2,3-trisubstituted with, in some embodiments, a 3-substituted-2,4,6-triiodophenyl aliphatic chain wherein the chain has a structure similar to naturally occurring fatty acids. In another embodiment, a monoiodophenyl aliphatic chain is utilized. Any position remaining on the triglyceride backbone is substituted with a saturated or unsaturated aliphatic hydrocarbon chain of the type found in naturally occurring fatty acids. The triglyceride analogs can be radioiodinated. In a preferred embodiment, a lipid emulsion is provided as the carrier vehicle.

    摘要翻译: 新型碘化芳基脂肪酸甘油三酯类似物作为放射剂是肝脏和肝细胞位点特异性。 甘油三酯主链结构优选在一些实施方案中被3-取代-2,4,6-三碘苯基脂族链进行1,3-二取代或1,2,3-三取代,其中链的结构类似于天然存在的脂肪 酸。 在另一个实施方案中,使用单碘苯基脂族链。 在甘油三酯主链上残留的任何位置被天然存在的脂肪酸中所发现类型的饱和或不饱和脂族烃链所取代。 甘油三酯类似物可以放射性碘化。 在优选的实施方案中,提供脂质乳剂作为载体载体。